Fighting Fat
Invest in

Fighting Fat

3.7%
8.7%
2.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
3.7%
8.7%
2.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
75.3% Diabetes Care 4.0%
25.7% Novo Nordisk A/S ADS NVO 23.6%
23.9% Sanofi-Aventis ADS SNY 8.1%
23.6% Merck & Co. Inc. MRK 7.2%
2.1% Greatbatch GB 26.5%
16.7% Weight Management 23.9%
6.3% NutriSystem Inc NTRI 77.2%
2.7% Weight Watchers International Inc. WTW 75.0%
2.7% Nu Skin Enterprises Inc. (A) NUS 11.9%
2.6% Medifast Inc. MED 16.6%
1.3% USANA Health Sciences Inc. USNA 106.2%
1.0% Vitamin Shoppe VSI 9.4%
7.9% Weight Loss Drugs 42.8%
5.0% Arena Pharmaceuticals Inc. ARNA 34.7%
2.4% Orexigen Therapeutics Inc. OREX 51.6%
0.6% VIVUS Inc. VVUS 73.7%